Replicating this GxE finding and understanding why OCT amplifies IBD or UC risk for some individuals but attenuates it in others, depending on genotype, could shed light on the role of hormone pathways in IBD pathogenesis. This evidence concerns the gene PLXNA2 and inflammatory bowel disease.